Chunhua Dai

February 20, 2020

Post-transplant diabetes may be reversible: study

Post-transplantation diabetes mellitus (PTDM), a common complication of immunosuppressive drugs that are given to prevent transplant rejection, may be reversible and at least partially preventable, researchers at VUMC report.

By Bill Snyder
November 29, 2018

Beta cell biomarker findings may speed diabetes research

Researchers at Vanderbilt University Medical Center have identified a biomarker for insulin-producing beta cells. Their finding, reported this month in the journal Cell Metabolism, could lead to improved ways to study and treat diabetes.

By Bill Snyder
September 21, 2017

Pancreatic islets study may spur diabetes treatment advances

Investigators in the Vanderbilt Diabetes Research and Training Center (VDRTC) and collaborators at Stanford University have discovered new insights into the molecular mechanisms of cell proliferation in juvenile human pancreatic islets, information that could lead to new treatments for diabetes.

By Jill Clendening
Insulin in vials
January 14, 2016

Major grants bolster VUMC diabetes research

Researchers at Vanderbilt University Medical Center have received more than $11 million in new grant support aimed at slowing the growing burden of diabetes.

By Bill Snyder
October 24, 2013

Study sheds new light on type 2 diabetes development

Inactivation by oxidative stress of specific transcription factors essential for pancreatic islet beta cell function is a key event in the development of type 2 diabetes, Vanderbilt University researchers and their colleagues have found.

By Bill Snyder